HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Free Full Text (PDF) Free All Versions of this Article: 100/6/1778    most recent 01405.2005v1 Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (13) Citing Articles via Google Scholar Google Scholar Articles by Barton, E. R. Search for Related Content PubMed PubMed Citation Articles by Barton, E. R.

Viral expression of insulin-like growth factor-I isoforms promotes different responses in skeletal muscle

Department of Anatomy and Cell Biology, School of Dental Medicine, and Pennsylvania Muscle Institute, University of Pennsylvania, Philadelphia, Pennsylvania

Submitted 7 November 2005 ; accepted in final form 20 January 2006

Insulin-like growth factor I (IGF-I) is a critical protein for skeletal muscle development and regeneration. Its ability to promote skeletal muscle hypertrophy has been demonstrated by several methods. Alternative splicing of the Igf-1 gene does not affect the mature IGF-I protein but does produce different E peptide extensions, which have been reported to modify the potency of IGF-I. Viral-mediated delivery of murine IGF-IA and IGF-IB into skeletal muscle of 2-wk-old and 6-mo-old mice was utilized to compare the effects of the isoforms on muscle mass. In young mice, tissue content of IGF-I protein was significantly higher in rAAV-treated muscles than control muscles at 1, 2, and 4 mo postinjection. Viral injection of IGF-IB produced two- to sevenfold more IGF-I than rAAVIGF-IA. Hypertrophy was observed 2 and 4 mo postinjection, where both rAAVIGF-IA and rAAVIGF-IB were equally effective in increasing muscle mass. These results suggest that there is a threshold of IGF-I production necessary to promote muscle hypertrophy in young growing animals regardless of isoform. In 6-mo-old animals, only rAAVIGF-IA produced significant increases in muscle size, even though increased IGF-I content was observed after injection of both isoforms. Therefore, the ability for IGF-IB to promote muscle hypertrophy is only effective in growing animals, suggesting that the bioavailability of this isoform or its receptor affinity diminishes with age.

adeno-associated virus; E peptide; IGF-I splicing

This article has been cited by other articles:

				S. D. R. Harridge Plasticity of human skeletal muscle: gene expression to in vivo function Exp Physiol, September 1, 2007; 92(5): 783 - 797. [Abstract] [Full Text] [PDF]

				M. M. Bamman, J. K. Petrella, J.-s. Kim, D. L. Mayhew, and J. M. Cross Cluster analysis tests the importance of myogenic gene expression during myofiber hypertrophy in humans J Appl Physiol, June 1, 2007; 102(6): 2232 - 2239. [Abstract] [Full Text] [PDF]

				V. Jacquemin, G. S. Butler-Browne, D. Furling, and V. Mouly IL-13 mediates the recruitment of reserve cells for fusion during IGF-1-induced hypertrophy of human myotubes J. Cell Sci., February 15, 2007; 120(4): 670 - 681. [Abstract] [Full Text] [PDF]

				J. K. Petrella, J.-s. Kim, J. M. Cross, D. J. Kosek, and M. M. Bamman Efficacy of myonuclear addition may explain differential myofiber growth among resistance-trained young and older men and women Am J Physiol Endocrinol Metab, November 1, 2006; 291(5): E937 - E946. [Abstract] [Full Text] [PDF]

				J. D. Schertzer, J. G. Ryall, and G. S. Lynch Systemic administration of IGF-I enhances oxidative status and reduces contraction-induced injury in skeletal muscles of mdx dystrophic mice Am J Physiol Endocrinol Metab, September 1, 2006; 291(3): E499 - E505. [Abstract] [Full Text] [PDF]

				F. Booth The many flavors of IGF-I J Appl Physiol, June 1, 2006; 100(6): 1755 - 1756. [Full Text] [PDF]